DocDollars

Ironshore Pharmaceuticals Inc.

NC · United States · Reporting entity ID 100000601811

Total reported 2019–2025
$7.73M
#573 of 2,960 reporting companies — 0% of all reported industry payments
$7.54M in general payments across 163,851 records, plus $194K in research funding across 20 records.

How it breaks down

General payments $7,539,980
Research funding $193,585

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Ironshore Pharmaceuticals Inc. reported $7.73M to US doctors and teaching hospitals from 2019 to 2025, ranking #573 of 2,960 reporting companies. 3% of that was research funding and 97% general payments such as consulting, speaking, food and travel. 163,851 general payment records and 20 research records were filed.

Common questions about Ironshore Pharmaceuticals Inc.

How much has Ironshore Pharmaceuticals Inc. paid US doctors?

Ironshore Pharmaceuticals Inc. reported $7,733,564 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $7,539,980 in general payments, $193,585 in research funding.

How does Ironshore Pharmaceuticals Inc. rank among drug and device companies?

It ranks #573 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Ironshore Pharmaceuticals Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.